文献速递肾小球疾病

系统综述:牛津MEST-C分类与IgA肾病补体激活的关联

Systematic Review of the Link Between Oxford MEST-C Classification and Complement Activation in IgA Nephropathy.
PubMed 文献 · Kidney Int Rep · 2023-11-14

该系统综述纳入34项研究共10,082例IgA肾病患者,评估补体激活与MEST-C分类的关联。结果显示所有检测的补体蛋白均与C1-2类相关,旁路和凝集素途径参与所有MEST-C分类。

要点

  • 所有补体蛋白均与MEST-C的C1-2类相关。
  • 旁路、凝集素和终末途径的特定蛋白独特存在于C1-2类。
  • C3、FHR5、C4和C4d与所有MEST-C分类相关。

核心结论

  • 证据支持旁路和凝集素补体途径参与所有MEST-C分类。
  • 所有检测的补体因子均与C1-2类相关,提示补体激活可能在内皮表面起关键作用。

研究设计与样本

  • 系统综述,遵循PRISMA指南,检索MEDLINE、Embase、Scopus和Cochrane数据库2016年1月至2023年1月。
  • 纳入34项研究共10,082例患者,其中7项儿科研究500例,22项亚洲人群研究8128例。

主要发现

  • 最常研究的补体蛋白包括C4d、C3、C5b9、MBL、C4和FHR5。
  • 补体激活评估主要采用肾活检标本的免疫荧光和免疫组化。
  • FB、FH、MASP1/3、MASP2、C5a和C5b9独特存在于C1-2类。
  • C3、FHR5、C4和C4d与所有MEST-C分类相关。

临床怎么用

  • 研究结果可能指导针对补体途径的个体化治疗策略开发,并与MEST-C病变相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: IgA nephropathy's (IgAN's) MEST-C classification relationship with complement activation is still not fully understood because of limited and conflicting evidence. Our study aimed to delineate this relationship through a systematic review. METHODS: We adhered to the Preferred Reporting Items for Systematic Review and Meta-analysis guidelines and conducted a systematic review, utilizing databases like MEDLINE (PubMed), Embase, Scopus, and Cochrane from January 2016 (year of updated MEST-C classification) to January 2023. We specifically selected studies that employed established methods to evaluate complement activation and the MEST-C classification. RESULTS: A total of 34 studies with 10,082 patients were included. Among these, 7 studies focused on the pediatric population (500 patients), and 22 studies involved 8128 patients from Asian populations. C4d, C3, C5b9, MBL, C4, and factor H-related protein 5 (FHR5) were the most frequently studied complement proteins in relation to the MEST-C classification. Complement activation assessment was primarily conducted using immunofluorescence and immunohistochemistry on kidney biopsy specimens. All complement proteins investigated showed associations with the C1-2 class. Notably, FB, FH, MASP1/3, MASP2, C5a, and C5b9 from the alternative, lectin, and terminal pathways were uniquely present in the C1-2 class. Whereas C3, FHR5, C4, and C4d were associated with all the MEST-C classes. CONCLUSION: We found evidence supporting the involvement of alternative and lectin complement pathways across all MEST-C classes. All examined complement factors were associated with the C1-2 class, emphasizing the critical role of complement activation, possibly at the endothelial surface. These findings may guide the development of personalized treatment strategies targeting complement pathways in relation to the MEST-C lesions.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Ștefan G, Alamartine E, Mariat C, et al. Systematic Review of the Link Between Oxford MEST-C Classification and Complement Activation in IgA Nephropathy. Kidney Int Rep. 2023. PMID: 38344730. doi:10.1016/j.ekir.2023.11.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。